Illumina, Inc. (ILMN)

Healthcare

$278.17

+5.14%

nightly snapshot · 10/11/2026

ALPHASCORE™ · B+ · Buy

ALPHASCORE

72

/ 100

B+

BUY

▲ 0 · 30D

KEY FUNDAMENTALS

P/E51.9

ROE31.2%

NET MARGIN19.6%

GROSS MARGIN66.1%

MKT CAP$42.00B

loading full analysis…

DAILY BRIEF

Illumina, Inc. displays an AlphaScore of 72/100, earning a B+ grade and a Buy signal on October 11, 2026. Key metrics showcase a high return on equity of 31.22% and a gross margin of 66.08%. A key strength is its strong quality profile and positive price momentum. A major risk is its negative revenue growth of -0.66% alongside a high price-to-earnings ratio of 51.90.

Written 11/10/2026, 00:34:21 UTC · Snapshot 11/10/2026